Oppenheimer Lowers athenahealth Price Target

Oppenheimer lowered its estimates and price target for athenahealth, Inc ATHN. athenahealth is a provider of Internet-based solutions for physicians. Oppenheimer analyst Charles Rhyee said, "With recent evidence of athenaClinicals gaining traction, we cautiously increase our expectation of top-line growth for 2010. However, expected increases in sales and marketing expenses, along with revenue contributions from lower-margin products, will likely impact EPS over the near and medium term." Oppenheimer revised its CY10 EPS to $0.49 from $0.52. It revised down its CY11 EPS to $0.73 from $0.78. Oppenheimer dropped its price target for athenahealth from $28 to $22. ATHN is rated Underperform, and is currently trading at $23.03. Learn how to find the best stocks to trade each day in our 70 page E-Book and 90 minute online video for free.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorInitiationAnalyst RatingsCharles RhyeeOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!